1. Home
  2. ATHE vs STRR Comparison

ATHE vs STRR Comparison

Compare ATHE & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • STRR
  • Stock Information
  • Founded
  • ATHE 1997
  • STRR 1985
  • Country
  • ATHE Australia
  • STRR United States
  • Employees
  • ATHE N/A
  • STRR N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ATHE Health Care
  • STRR Health Care
  • Exchange
  • ATHE Nasdaq
  • STRR Nasdaq
  • Market Cap
  • ATHE 10.1M
  • STRR 9.4M
  • IPO Year
  • ATHE N/A
  • STRR N/A
  • Fundamental
  • Price
  • ATHE $1.07
  • STRR $2.94
  • Analyst Decision
  • ATHE Buy
  • STRR
  • Analyst Count
  • ATHE 1
  • STRR 0
  • Target Price
  • ATHE $4.00
  • STRR N/A
  • AVG Volume (30 Days)
  • ATHE 13.7K
  • STRR 11.3K
  • Earning Date
  • ATHE 12-03-2024
  • STRR 11-19-2024
  • Dividend Yield
  • ATHE N/A
  • STRR N/A
  • EPS Growth
  • ATHE N/A
  • STRR N/A
  • EPS
  • ATHE N/A
  • STRR N/A
  • Revenue
  • ATHE $2,681,669.00
  • STRR $50,375,000.00
  • Revenue This Year
  • ATHE N/A
  • STRR $19.97
  • Revenue Next Year
  • ATHE N/A
  • STRR $41.50
  • P/E Ratio
  • ATHE N/A
  • STRR N/A
  • Revenue Growth
  • ATHE 2.63
  • STRR 2.22
  • 52 Week Low
  • ATHE $1.00
  • STRR $2.73
  • 52 Week High
  • ATHE $5.41
  • STRR $6.55
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 37.45
  • STRR 25.90
  • Support Level
  • ATHE $1.05
  • STRR $2.73
  • Resistance Level
  • ATHE $1.13
  • STRR $3.50
  • Average True Range (ATR)
  • ATHE 0.07
  • STRR 0.30
  • MACD
  • ATHE -0.01
  • STRR -0.04
  • Stochastic Oscillator
  • ATHE 23.88
  • STRR 19.09

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

Share on Social Networks: